Clinical Trials

Clinical Trials Currently Recruiting

See below for further details, or contact us at

SNDX-5613 Clinical Trials

A Study of SNDX-5613 in R/R Leukemias Including Those With an MLLr/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101).

Axatilimab Clinical Trials

A Phase 2, Open-label, Randomized, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of Axatilimab at 3 Different Doses in Patients With Recurrent or Refractory Active Chronic Graft Versus Host Disease Who Have Received at Least 2 Lines of Systemic Therapy.

To learn more about our clinical trials, please contact us at

Syndax is very interested in pursuing innovative explorations in science. If you are interested in collaborating with us, please contact us through